Q2 2024 Earnings Estimate for Biogen Inc. Issued By Wedbush

Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities researchers at Wedbush reduced their Q2 2024 earnings per share estimates for shares of Biogen in a note issued to investors on Wednesday, April 24th. Wedbush analyst L. Chico now anticipates that the biotechnology company will earn $3.43 per share for the quarter, down from their prior […]

Related Keywords

Germany , Illinois , United States , Piper Sandler , Erick Rowinsky , Priya Singhal , Biogen Inc , A Global Asset Management Inc , Dynamic Advisor Solutions , Boone Capital Management , Biogen Company Profile , Securities Exchange Commission , Prudential Asset Management Co Ltd , Illinois Municipal Retirement Fund , Nasdaq , Needham Company , Jpmorgan Chase Co , Free Report , Get Free Report , Asset Management Co Ltd , Capital Management , Global Asset Management , Municipal Retirement Fund , Advisor Solutions , Exchange Commission , Director Eric , Biogen Daily , Biogen , Nasdaq Biib , Biib , Medical , 09062x10 , Earnings Estimates , Wedbush ,